Asparagine–glycine–arginine–human tumour necrosis factor (NGR–hTNF) is a vascular targeting agent exploiting a tumour-homing peptide (NGR) that selectively binds to aminopeptidase N/CD13, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback